RosTrace

Robin Hayes

Latest from Robin Hayes

Robin Hayes

Animal Study Uncovers Distinct Metabolic Effects of Tirzepatide Versus Semaglutide

New preclinical research presented at the 2025 European Congress on Obesity (ECO) in Malaga, Spain, reveals that the anti-obesity drugs tirzepatide and semaglutide produce markedly different short-term metabolic responses in mice. While tirzepatide transiently increases energy expenditure, semaglutide initially suppresses it. Both agents, however, converge on enhanced fat oxidation and appetite suppression, with the most pronounced metabolic shifts occurring during active treatment and rapidly waning once dosing ceases.

· 5 min read

Robin Hayes

Hearing Aids May Help Older Adults Combat Social Isolation

Social isolation and loneliness have reached crisis levels among older Americans, with more than one in four seniors reporting little or no contact with others and a third feeling persistently lonely. Researchers and public health officials have linked these trends to a host of adverse outcomes—including depression, cognitive decline, heart disease and increased mortality. While factors such as mobility limitations and loss of loved ones play key roles, untreated hearing loss emerges as a significant contributor to diminishing social engagement.

· 6 min read

Robin Hayes

FDA Approves First At-Home HPV Test as Alternative to In-Office Pap Smear

On May 11, 2025, the U.S. Food and Drug Administration (FDA) granted approval for the country’s first at-home human papillomavirus (HPV) test designed as an optional alternative to the traditional in-office Pap smear. Manufactured by MedAware Diagnostics (a subsidiary of Hackensack Meridian Health), the test enables individuals with a cervix to collect their own vaginal sample via a soft, sponge-like swab. Following a telehealth consultation, patients mail their specimens to a central laboratory for HPV analysis. Those who receive a positive result are promptly referred for an in-office Pap smear and follow-up care, while patients testing negative can safely defer further screening for three to five years in accordance with established guidelines.

· 6 min read

Robin Hayes

Illicit Fentanyl Use in the U.S. Far Higher than Previously Reported

A groundbreaking new study by RAND Corporation and the University of Southern California reveals that illicit opioid use—particularly of nonprescription fentanyl—is far more widespread in the United States than official estimates have indicated. In an online survey of 1,515 American adults conducted in June 2024, researchers found that 11 percent reported using illicit opioids in the past year, and 7.5 percent reported use of illicitly manufactured fentanyl. These figures dwarf the 0.3 percent fentanyl prevalence reported by the National Survey on Drug Use and Health (NSDUH) in 2022, underscoring a critical need for more accurate, near–real-time monitoring tools to guide the nation’s response to the ongoing opioid crisis.

· 5 min read

Robin Hayes

Expanded Access to Influenza Vaccination as NSW Pharmacists Begin Immunising Children Aged Two and Above

The New South Wales Government has announced a significant expansion of its influenza vaccination program, permitting qualified pharmacists to administer flu shots to children as young as two years old. The move, welcomed by the Pharmaceutical Society of Australia (PSA), aims to increase immunisation rates among young families, reduce barriers to access and ultimately curb the seasonal surge in influenza cases. With vaccination coverage among the six-month to five-year age group declining in recent years, health authorities are calling on all immunisation providers—GPs, nurse practitioners and pharmacists—to collaborate in safeguarding New South Wales communities this winter.

· 7 min read

Robin Hayes

What Is a Blood Cholesterol Ratio? And What Should Yours Be?

The results of a routine blood test can reveal more than just your total cholesterol level. Clinicians increasingly turn to blood cholesterol ratios—comparisons between different types of lipids in your bloodstream—to assess cardiovascular risk with greater precision. Unlike single biomarkers, these ratios integrate both “good” and “bad” cholesterol components, offering a more holistic view of arterial health. With heart disease remaining Australia’s leading cause of death, understanding and optimizing your cholesterol ratios could be the key to longer, healthier life.

· 5 min read

Robin Hayes

Teen Movement Matters: Norwegian Study Finds More Activity at 14 Slashes Depression Risk

A team at the Norwegian University of Science and Technology (NTNU) has delivered some of the strongest evidence to date that boosting physical activity during the mid‑teen years can help keep depression at bay. By following a birth cohort of 873 young people from childhood to adulthood, the researchers showed that adolescents who became more active between ages 14 and 18 were significantly less likely to develop depressive symptoms two years later. The peer‑reviewed findings appear in the Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP).

· 4 min read

Robin Hayes

Early Knee Damage Found in 30-Somethings Without Symptoms, Study Shows

Structural changes commonly linked to joint degeneration are being detected in the knees of people in their early thirties—even in the absence of pain or other symptoms, according to a new study from the University of Oulu, Finland. The findings, published in Osteoarthritis and Cartilage, suggest that early joint damage may begin well before clinical symptoms appear, and that weight plays a pivotal role in these changes.

· 4 min read

Robin Hayes

Improving Outcomes for Gastro–Oesophageal Cancer: The Case for Early Specialist and Endoscopic Referral

Gastro–oesophageal cancers, encompassing stomach and oesophageal malignancies, are increasingly impacting populations in Western societies—including younger individuals. In Australia alone, the age-standardised incidence for stomach cancer in 2024 was 7.6 per 100,000 persons, and 5.1 per 100,000 for oesophageal cancers. Despite substantial improvements in diagnostic imaging, surgical techniques, oncology treatments, and supportive care, these cancers continue to have significantly lower 5-year survival rates than the overall average for all cancers. Compared to the national average survival rate of 71.2%, stomach cancer remains at 38%, and oesophageal cancer at just 23%.

· 4 min read

Robin Hayes

Endometriosis May Double Risk of Premature Menopause, Large Global Study Finds

A new global study from the University of Queensland has found that women with endometriosis are significantly more likely to experience premature or early menopause—especially if brought on by surgery—posing long-term risks to their health. Drawing on data from nearly 280,000 women across Australia, the UK, Sweden, and Japan, the research provides the most extensive evidence to date that endometriosis can influence not only fertility but also the timing and type of menopause.

· 3 min read

Robin Hayes

New Studies Reveal Alarming Links Between Tobacco, Cannabis Use and Cardiovascular Disease

New clinical evidence presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions has drawn renewed attention to the growing cardiovascular risks associated with two of the most widely used substances in the United States: tobacco and cannabis. According to researchers, coronary heart disease deaths tied to tobacco use are projected to increase by nearly 44% within the next five years, while people with cannabis use disorder (CUD) are significantly more likely to suffer from serious heart complications including heart attacks and arrhythmias.

· 4 min read